We will use cookies and other information to optimize your experience. By continuing to browse, you consent to our use. For details, please read Privacy Policy
RuenHuei Biopharmaceuticals Inc.
Language
  • English
  • 繁體中文
  • ABOUT US
    • Company Overview
    • Juine-Ruey (JR) Chen Ph.D
    • Management Team
  • NEWS
    • Media
    • Interview
  • PIPELINE
    • Overview
    • Flu Vaccine Platform
    • C34 Adjuvant Formulation
  • PRODUCTS
  • CONTACT
  1. Home
  2. NEWS
NEWS
  • Media
  • Interview
Media
  • 182019.01
    Development of monoglycosyalated HA (HAmg) as a universal flu vaccine.
CONTACTS
  • Tel 02-33937128
  • Mail service@rhbiopharma.com
  • Address 4F., No. 33, Linsen S. Rd., Zhongzheng Dist., Taipei City 100, Taiwan
NAVIGATION
  • ABOUT US
  • NEWS
  • PIPELINE
  • PRODUCTS
  • MESSAGE
  • CONTACT
  • TERMS
  • DISCLAIMER

Copyright © RuenHuei Biopharmaceuticals Inc. All Rights Reserved. Web Design : DOMINO

  • English
  • 繁體中文
Language
  • English
  • 繁體中文
  • ABOUT US
    • Company Overview
    • Juine-Ruey (JR) Chen Ph.D
    • Management Team
  • NEWS
    • Media
    • Interview
  • PIPELINE
    • Overview
    • Flu Vaccine Platform
    • C34 Adjuvant Formulation
  • PRODUCTS
  • CONTACT